Ericsson to back UNICEF’s efforts against COVID-19 pandemic in India
Category: #headlines  By Nikita Chaurasia  Date: 2021-06-08
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Ericsson to back UNICEF’s efforts against COVID-19 pandemic in India

Renowned multinational networking and telecommunications giant Telefonaktiebolaget LM Ericsson has announced that it will support UNICEF in addressing urgent healthcare needs in India that have arisen amid the second wave of the COVID-19 pandemic.

If sources are to be believed, Ericsson has made an upfront contribution to UNICEF and has also started a month-old entity matching employee donation drive worldwide in May 2021. Ericsson employees from more than 95 countries have participated in this initiative and a sum of USD 971,567 was collected.

This donation will aid India to deal with the surge in the number of COVID-19 cases and the shortage of medical equipment by providing critical medical supplies. The funds will also allow UNICEF to increase the number of RT-PCR testing machines will be increased in India which will result in quick identification of new COVID-19 cases.

Furthermore, these funds will be utilized to set up various oxygen generation plants in the country and procure other critical medical supplies for health facilities. This will further ensure sustained access to immediate healthcare for children and their families while strengthening India’s health infrastructure, cited sources.

Deeming India as a critical market, Vice President for Sustainability and Corporate Social Responsibility for Ericsson, Heather Johnson reportedly many of the company’s employees worldwide have inquired about how they could help the country during the pandemic which in turn had prompted a partnership with UNICEF.

UNICEF’s Deputy Executive Director for Partnerships Charlotte Petri Gornitzka was quoted saying that the organization is working tirelessly with its partners to ensure the provision and speedy delivery of urgent medical equipment and supplies in India and thus save precious lives.

It is worth mentioning that Ericsson had previously supported initiatives like collecting COVID-19 test samples for testing at government labs in Pune and Chennai in 2020. The Swedish giant has donated several PPE kits to sanitation workers and hospitals as well.

 Source Credits –

https://telecom.economictimes.indiatimes.com/news/ericsson-supports-unicef-in-the-fight-against-covid-19-pandemic-in-india/83302048

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Coretec Group, Eindhoven University join hands for research works

Coretec Group, Eindhoven University join hands for research works

By Nikita Chaurasia

U.S.-based new silicon products pioneer Coretec Group Inc. has reportedly entered into a research partnership with Eindhoven University of Technology (TU/e), which is among the leading 50 universities in engineering and technology globally as per QS ...

FedEx partners with Nuro to develop autonomous package delivery systems

FedEx partners with Nuro to develop autonomous package delivery systems

By Nikita Chaurasia

FedEx Corporation and robotics startup Nuro have reportedly signed a multi-year agreement to develop and test last-mile delivery using autonomous vehicles. The American multinational delivery giant will be using its Houston facility for the pilot pro...

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

By Nikita Chaurasia

According to reliable sources, Natco Pharma’s marketing partner Breckenridge Pharmaceutical Inc. has obtained approval from U.S. Food and Drug Administration (USFDA), for its anti-cancer drug Carfilzomib Vials. For the record, Carfilzomib Vial...